Mead Johnson Nutrition Co: (NYSE: MJN)
$83.01
1.66 (2.04%)
Volume 1,012,254
Jun 17 04:02 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 81.66 - 83.67 |
| 52wk Low - High | 61.27 - 88.72 |
| Previous Close | 81.35 |
| Avg. Volume | 1,425,912 |
| Industry | MED PRODUCTS |
| Market Cap | 16.47 B |
| Div - Yield | 1.36 - 1.67 |
| Beta | 0.47 |
| P/E (F1) | 24.73 |
| Current Year Est. | 3.29 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
183 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| P/E (F1) | 24.73 |
| PEG Ratio | 2.25 |
| Current Year Est. | 3.29 |
| Current Quarter Estimate | 0.84 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 07-25-2013 |
| EPS Last Year | 3.11 |
| Expected Earnings Growth | 11.00% |
Company Description
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's Enfa family of brands, including Enfamil? infant formula, is the world's leading brand franchise in pediatric nutrition.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.84 | 0.83 | 3.29 | 3.70 |
| Number of Estimates | 9 | 8 | 11 | 10 |
| Low Estimate | 0.81 | 0.77 | 3.24 | 3.55 |
| High Estimate | 0.91 | 0.93 | 3.50 | NA |
| Year Ago EPS | 0.83 | 0.71 | 3.08 | 3.29 |
| EPS Growth | 1.20% | 16.73% | 6.82% | 12.52% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| MEAD JOHNSON NU | MJN | 81.35 | |
|
| HAEMONETICS CP | HAE | 42.24 | |
|
| ATRICURE INC | ATRC | 9.00 | |
|
| BAXANO SURGICAL | BAXS | 2.24 | |
|
| CARDICA INC | CRDC | 1.17 | |
|
| INVIVO THERAPT | NVIV | 4.00 | |
|
| SHANDONG WEIGAO | SHWGF | 1.29 | |
|
| ABAXIS INC | ABAX | 46.53 | |
|
| ADVAXIS INC | ADXS | 0.04 | |
|
| BAXTER INTL | BAX | 70.60 | |
|
Sector:Medical>> Industry:MED PRODUCTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Financials
| EPS TTM | 3.11 |
| Sales | 3,901 |
| Net Income | 613 |
| Price/Earnings | 26.16 |
| Price/Book | 185.68 |
| Price/Cash Flow | 23.36 |
| Price/Sales | 4.17 |
News
Buyers Accumulate Shares of Mead Johnson Nutrition, Up 2.6% - Financial News Network Online - Market Movers
Jun 17, 2013
Mead Johnson Nutrition (MJN) Crosses Pivot Point Resistance at $82.34 - Financial News Network Online - Pivot Alerts
Jun 17, 2013
Mead Johnson Nutrition Bullish Moving Average Crossover Alert (MJN) - Financial News Network Online - Moving Average Crossovers
Jun 17, 2013
US Nutraceuticals Market Forecast to 2017 - M2
Jun 17, 2013
Mead Johnson Nutrition (MJN) Trading Near $83.48 Resistance Level - Freshbrewedmedia
Jun 14, 2013
Daily Dividend Report: ARR, MSFT, UTX, DELL, MJN - Marketnewsvideo.Com
Jun 13, 2013
Mead Johnson Board of Directors Declares Dividend - Businesswire
Jun 13, 2013
These Companies Have a Formula for Success - TheMotleyFool
Jun 12, 2013
Broker Recommendations
| Current ABR | 2.05 |
| ABR (Last Week) | 2.05 |
| # of recs in ABR | 10 |
| Average Target Price | 84.14 |
| Industry Rank by ABR | 183 out of 265 |
| Rank in Industry | 6 out of 72 |
